CRISPR

5 Novel Therapies Using Synthetic Biology

The 1997 film “Gattaca” promised a future where humans would be free of disease and babies born on demand with the latest upgrades, including enhanced speed, intelligence, and beauty. Much like a new Tesla Roadster. However, despite the technological predictions offered by Hollywood moviemakers, we’re still living in a time when synthetic biology is working […]

When Will Xenotransplantation of Pig Organs Be Possible?

We recently profiled eight companies creating exotic lab-based foods. Dubbed cellular agriculture, the technology to grow meat from animal cells has advanced swiftly in just a few years. One of the first commercial products just hit the menu at a Singaporean restaurant. At $23 for four chicken nuggets, it’s still more of a novelty than […]

Gene-Editing AgTech Startup for Growing Better Food

People often talk about food as the great unifier across cultures and peoples, even European football fans. But that’s really a load of bollocks, innit, bruv? In our current age of yin-yang dystopia, food itself can be divisive. One of Canada’s most well-known national treasures, poutine, has created internal strife over who owns the rights […]

The Rapid Rise of Gene Editing Stocks

When you try not to check in on your stocks very often, life comes at you fast. Sometimes, that’s a good thing. Gene editing stocks have been on an absolute tear, at least the three we’re holding in our portfolio. Just look at the 30-day returns for the three OGs of gene editing stocks. Editas […]

How Plant Sciences Will Feed 10 Billion People By 2050

Regular readers know that we don’t just publish articles, but foster a conversation about emerging technologies and how they will improve the world (and our investment portfolio). One of our ongoing themes – aside from Elon Musk’s hair – is how this little green and blue ball we inhabit can continue to sustain life as […]

6 CRISPR Applications from Healthcare Startups

One question we’re often asked at Nanalyze is what emerging technology do we think will be most disruptive in the long term. The short answer: All of them. Otherwise, we wouldn’t be devoting long hours at the laptop between trips to the local dispensary writing about all of this amazing progress. Artificial intelligence, as we’ve […]

A Few Updates on the Progress of Gene Editing

Whenever an exciting technology comes along, people want to invest in it. Even if those people have never put a single red penny into the stock market, they will suddenly start buying stocks with no regard towards the basic principles of prudent investing like diversifying your holdings and not investing in over-the-counter (OTC) stocks. To […]

Synthego and Synthetic Guide RNA Explained

Nobody could have possibly predicted what we all recently witnessed in awe. Some people reacted with hope and optimism, others with fear. Could things really have gotten to this point? Could anybody have predicted that society would be in the situation that it sits today? That a giant orange blob would be the focal point of nations around […]

Investing in CRISPR: Which Gene Editing Stock to Buy?

We’ve talked before about gene editing and a technique called CRISPR or CRISPR Cas9 that allows us to start changing DNA such that we can do useful things like create nanobots or eradicate inherited diseases. A while back we highlighted 7 companies playing in the gene editing space and at the time we wrote that original […]

Gene Editing Company Editas Files for IPO

2016 hasn’t started out too well for equity investors, with the S&P 500 dropping -6% in the first week of 2016 trading alone. This doesn’t bode well for IPOs, especially for biotech IPOs, which were hot in 2015 but have been punished as of late. One of our most popular articles in the past few months has […]